Tag: 2026
Rajasthan Recalls Labour-Inducing Gel Over Quality Test Failure
Rajasthan's Drug Control Department has ordered an immediate recall of a specific batch of Dinoprostone Gel, a critical drug commonly used to induce labour and soften...
skillzMap and PharmaGenDRx Sign Strategic MoU to Accelerate Skill Development in the Pharmaceutical and Life Sciences Sector
PharmaGenDRx, one of India's emerging platforms dedicated to pharmaceutical education, industry engagement, and career development, has signed a Memorandum of Understanding (MoU) with SkillzMap, a leading skill...
Maharashtra State Pharmacy Council Partners with IPC to Launch Dedicated “Pharmacovigilance & Medicine Safety” Web Portal
The Maharashtra State Pharmacy Council (MSPC), in a strategic collaboration with the Indian Pharmacopoeia Commission (IPC), announced the official launch of a dedicated “Pharmacovigilance...
FDA Grants Accelerated Approval to Vera Therapeutics’ TRUTAKNA™️ for Primary IgA Nephropathy
Vera Therapeutics, Inc. (Nasdaq: VERA) announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to TRUTAKNA™ (atacicept-vymj). The therapy is...
IPA Bengal Observes International Rational Use of Medicines Day 2026, Urges ‘Prescribe with Purpose, Use with Care’
The Indian Pharmaceutical Association (IPA) Bengal Branch, in association with the IPA Bengal Pharma and Healthcare Trust, observed International Rational Use of Medicine Day...
Pinnacle Life Science Becomes First to Launch Generic Blood Cancer Drug Venetoclax in India, Reducing Costs by 75%
In a major breakthrough for affordable oncology care, Pinnacle Life Science Pvt. Ltd., a subsidiary of Aarti Drugs, has officially launched Venetoclax in India. With this milestone, Pinnacle becomes the...